Combination of interleukin-12 gene therapy, metronomic cyclophosphamide and DNA cancer vaccination directs all arms of the immune system towards tumor eradication

A combination treatment of intratumoral interleukin-12 gene therapy, metronomic cyclophosphamide and genetic vaccination results in 89% cure rate in a melanoma mouse model.66